OMERS Administration Corporation »

Taysha Gene Therapies shares owned by OMERS Administration Corporation

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by OMERS Administration Corporation from 13F filings

Historical chart of OMERS Administration Corporation investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by OMERS Administration Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by OMERS Administration Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $403k 59k 6.81
2025-06-30 $168k 73k 2.31
2024-03-31 $80k 28k 2.87

More positions owned by OMERS Administration Corporation

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Brookfield Business Corp Cl A Sub Vtg Sh (BBUC)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Micron Technology (MU)
Canadian Natural Resources (CNQ)
Broadcom (AVGO)
Citigroup Com New (C)

View all positions for OMERS Administration Corporation

Top funds holding Taysha Gene Therapies

venBio Select Advisor
RA Capital Management
Goldman Sachs Group
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Capital Management
State Street Corporation
Siren
Octagon Capital Advisors
Geode Capital Management
Polar Capital Holdings
MPM Oncology Impact Management

View all funds holding Taysha Gene Therapies